Navigation Links
Increases in West Nile Virus Replikin Concentrations Precede Increases in the Number of Human Cases
Date:5/2/2008

BOSTON, May 2 /PRNewswire/ -- Replikins Ltd. has found that the replikin concentration of West Nile Virus increased annually through two distinct cycles as the virus expanded in the U.S.: the first from 2000 to 2003, and the second from 2004 to 2007 (p less than 0.001). Increases in the annual number of human cases followed each of the virus replikin concentration increases.

Replikins are peptides, specified in virus genomes, which increase in concentration signaling rapid replication before virus outbreaks. This is the first report that cyclic increases in virus replikin concentration, each apparently building on the last, can be a mechanism of virus expansion into a territory.

In the present study, virus ReplikinCount(TM) determined by FluForecast(TM) software was correlated with CDC epidemiological data on the number of human cases per year. Discrete cycles were distinguished within, and correlated between, virus chemistry and host morbidity. The mosquito-borne West Nile virus, which apparently incubates between seasons, has been found to increase its concentration of Replikins before the next annual step in the cycle of expansion.

This demonstration of replikin cycles represents further "proof of principle" on the relationship of replikins to virus epidemics, and a new means of discerning the course of an epidemic. Previously, increases in the ReplikinCount of the Replikins Peak Gene were found to precede and to predict outbreaks and lethality of two other viruses, influenza H5N1 and Taura Syndrome Virus, in two hosts, human and shrimp respectively. The conservation of specific replikin structures over many years, the detection of new replikins, and the chemical synthesis of replikin vaccines in 7 days, demonstrated for H5N1 and Taura Syndrome viruses, have now also been demonstrated for West Nile Virus.

For further information, Google "replikins," and see U.S. Patent Office publications.

Contact:

Replikins Ltd., 38 The Fenway, Boston MA 02215

email: sbogoch@replikins.com

Tel: 646-320-5910

http://www.Replikins.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Replikins Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
2. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
3. Demand for VScan Dengue Fever Test Kits Increases
4. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
5. The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy
6. Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics
7. Emisphere Announces Second Study Demonstrating Dramatic Increases in Absorption of Oral B12 Using eligen(R) Technology at Lower Doses
8. New Data Shows Ranexa(R) Increases Glucose-Stimulated Insulin Secretion
9. Orqis(R) Medicals Cancion(R) System Significantly Increases Cardiac Performance
10. Replikins LLC Finds West Nile Virus Replikin Count Has Reached Its Highest Recorded Value
11. Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... 2016 Yissum Research Development ... today that it had signed an exclusive world-wide licensing ... of novel protein degradation and immunomodulatory drugs for cancer ... drug candidates representing first-in-class therapy for hematologic and solid ... The novel technology was developed by ...
(Date:5/4/2016)... , May 4, 2016 ... of the  "Global Acute Myeloid Leukemia Market ... to their offering.       (Logo: ... Myeloid Leukemia Market and Competitive Landscape Highlights ... Leukemia pipeline products, Acute Myeloid Leukemia epidemiology, ...
(Date:5/3/2016)... , May 4, 2016 Research ... "Global Cancer Stem Cell Therapy Market Outlook 2020" ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,Recombinant technology has improved significantly ... expected to be developed in coming years. Many cancer ... Cancer stem cell therapies are also expected to be ...
Breaking Medicine Technology:
(Date:5/5/2016)... ... May 05, 2016 , ... A local study examining asthma ... 40 percent of participating fifth-grade students already have or are at risk for ... Research in the Division of Pulmonary, Allergy and Critical Care Medicine at ...
(Date:5/5/2016)... ... 2016 , ... Sun Health registered nurse Brittany Eads and ... Care Transitions program at the 9th Annual Orthopedic and Spine Summit held ... Post-Acute Environment Through Effective Transitions of Care.” , Major changes are taking place ...
(Date:5/5/2016)... ... (PRWEB) May 05, 2016 , ... Talent Tech Labs (TTL) ... the eve of National Nurses Week (May 6-12). Currently, HireNurses is a ... their enrollment into the Talent Tech Lab Virtual Incubation program, they will dramatically expand ...
(Date:5/5/2016)... (PRWEB) , ... May 05, 2016 , ... The Lung Institute will celebrate ... attending a seminar at most clinic locations throughout the month of May. To date, the ... , “The rapid growth that we’ve seen is a testament to the success of this ...
(Date:5/5/2016)... ... May 05, 2016 , ... With May flowers, summer is just around the corner. Summer means ... respite from school and the ability to play all day and night. Parents often lament ... watch the little tykes themselves. Summer also means trips to the beach, backyard cookouts, fireworks ...
Breaking Medicine News(10 mins):